|
1
|
Calleja-Agius J and Brincat M: The effect
of menopause on the skin and other connective tissues. Gynecol
Endocrinol. 28:273–277. 2012. View Article : Google Scholar
|
|
2
|
Hall G and Phillips TJ: Estrogen and skin:
the effects of estrogen, menopause, and hormone replacement therapy
on the skin. J Am Acad Dermatol. 53:555–568; quiz 569–572. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kloepper JE, Tiede S, Brinckmann J,
Reinhardt DP, Meyer W, Faessler R and Paus R: Immunophenotyping of
the human bulge region: the quest to define useful in situ markers
for human epithelial hair follicle stem cells and their niche. Exp
Dermatol. 17:592–609. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Archer DF: Postmenopausal skin and
estrogen. Gynecol Endocrinol. 28(Suppl 2): 2–6. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ashcroft GS, Mills SJ, Lei K, Gibbons L,
Jeong MJ, Taniguchi M, Burow M, Horan MA, Wahl SM and Nakayama T:
Estrogen modulates cutaneous wound healing by downregulating
macrophage migration inhibitory factor. J Clin Invest.
111:1309–1318. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gilliver SC, Emmerson E, Bernhagen J and
Hardman MJ: MIF: a key player in cutaneous biology and wound
healing. Exp Dermatol. 20:1–6. 2011. View Article : Google Scholar
|
|
7
|
Ashcroft GS, Dodsworth J, van Boxtel E,
Tarnuzzer RW, Horan MA, Schultz GS and Ferguson MW: Estrogen
accelerates cutaneous wound healing associated with an increase in
TGF-beta1 levels. Nat Med. 3:1209–1215. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li X, Bai J, Ji X, Li R, Xuan Y and Wang
Y: Comprehensive char-acterization of four different populations of
human mesenchymal stem cells as regards their immune properties,
proliferation and differentiation. Int J Mol Med. 34:695–704.
2014.PubMed/NCBI
|
|
9
|
Zhu T, Park HC, Son KM, Kwon JH, Park JC
and Yang HC: Effects of thymosin β4 on wound healing of rat palatal
mucosa. Int J Mol Med. 34:816–821. 2014.PubMed/NCBI
|
|
10
|
Liu H, Du L, Wen Z, Yang Y, Li J, Dong Z,
Zheng G, Wang L, Zhang X and Wang C: Sex determining region Y-box 2
inhibits the proliferation of colorectal adenocarcinoma cells
through the mTOR signaling pathway. Int J Mol Med. 32:59–66.
2013.PubMed/NCBI
|
|
11
|
Törmä H, Lindberg M and Berne B: Skin
barrier disruption by sodium lauryl sulfate-exposure alters the
expressions of involucrin, transglutaminase 1, profilaggrin, and
kallikreins during the repair phase in human skin in vivo. J Invest
Dermatol. 128:1212–1219. 2008. View Article : Google Scholar
|
|
12
|
Freedberg IM, Tomic-Canic M, Komine M and
Blumenberg M: Keratins and the keratinocyte activation cycle. J
Invest Dermatol. 116:633–640. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reichelt J, Büssow H, Grund C and Magin
TM: Formation of a normal epidermis supported by increased
stability of keratins 5 and 14 in keratin 10 null mice. Mol Biol
Cell. 12:1557–1568. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Carter CA, Jolly DG, Worden CE Sr, Hendren
DG and Kane CJ: Platelet-rich plasma gel promotes differentiation
and regeneration during equine wound healing. Exp Mol Pathol.
74:244–255. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peryassu MA, Cotta-Pereira G,
Ramos-e-Silva M and Filgueira AL: Expression of keratins 14, 10 and
16 in marginal keratoderma of the palms. Acta Dermatovenerol Croat.
13:206–211. 2005.PubMed/NCBI
|
|
16
|
Michel M, Török N, Godbout MJ, Lussier M,
Gaudreau P, Royal A and Germain L: Keratin 19 as a biochemical
marker of skin stem cells in vivo and in vitro: keratin 19
expressing cells are differentially localized in function of
anatomic sites, and their number varies with donor age and culture
stage. J Cell Sci. 109:1017–1028. 1996.PubMed/NCBI
|
|
17
|
Dvoránková B, Smetana K Jr, Chovanec M,
Lacina L, Stork J, Plzáková Z, Galovicová M and Gabius HJ:
Transient expression of keratin 19 is induced in originally
negative interfollicular epidermal cells by adhesion of suspended
cells. Int J Mol Med. 16:525–531. 2005.PubMed/NCBI
|
|
18
|
Gabius HJ, André S, Jiménez-Barbero J,
Romero A and Solís D: From lectin structure to functional
glycomics: principles of the sugar code. Trends Biochem Sci.
36:298–313. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
André S, Kaltner H, Manning JC, Murphy PV
and Gabius HJ: Lectins: getting familiar with translators of the
sugar code. Molecules. 20:1788–1823. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Solís D, Bovin NV, Davis AP,
Jiménez-Barbero J, Romero A, Roy R, Smetana K Jr and Gabius HJ: A
guide into glycosciences: How chemistry, biochemistry and biology
cooperate to crack the sugar code. Biochim Biophys Acta.
1850:186–235. 2015. View Article : Google Scholar
|
|
21
|
Villalobo A, Nogales-Gonzalez A and Gabius
HJ: A guide to signaling pathways connecting protein-glycan
interaction with the emerging versatile effector functionality of
mammalian lectins. Trends Glycosci Glyc. 18:1–37. 2006. View Article : Google Scholar
|
|
22
|
Kaltner H and Gabius HJ: A toolbox of
lectins for translating the sugar code: the galectin network in
phylogenesis and tumors. Histol Histopathol. 27:397–416.
2012.PubMed/NCBI
|
|
23
|
Katzenmaier EM, André S, Kopitz J and
Gabius HJ: Impact of sodium butyrate on the network of
adhesion/growth-regulatory galectins in human colon cancer in
vitro. Anticancer Res. 34:5429–5438. 2014.PubMed/NCBI
|
|
24
|
Nagy N, Bronckart Y, Camby I, Legendre H,
Lahm H, Kaltner H, Hadari Y, Van Ham P, Yeaton P, Pector JC, et al:
Galectin-8 expression decreases in cancer compared with normal and
dysplastic human colon tissue and acts significantly on human colon
cancer cell migration as a suppressor. Gut. 50:392–401. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Klíma J, Lacina L, Dvoránková B, Herrmann
D, Carnwath JW, Niemann H, Kaltner H, André S, Motlík J, Gabius HJ
and Smetana K Jr: Differential regulation of galectin
expression/reactivity during wound healing in porcine skin and in
cultures of epidermal cells with functional impact on migration.
Physiol Res. 58:873–884. 2009.
|
|
26
|
Dvořánková B, Szabo P, Lacina L, Gal P,
Uhrova J, Zima T, Kaltner H, André S, Gabius HJ, Sykova E, et al:
Human galectins induce conversion of dermal fibroblasts into
myofibroblasts and production of extracellular matrix: potential
application in tissue engineering and wound repair. Cells Tissues
Organs. 194:469–480. 2011. View Article : Google Scholar
|
|
27
|
Teichberg VI, Silman I, Beitsch DD and
Resheff G: A beta-D-galactoside binding protein from electric organ
tissue of Electrophorus electricus. Proc Natl Acad Sci USA.
72:1383–1387. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gabius HJ, Engelhardt R, Cramer F, Bätge R
and Nagel GA: Pattern of endogenous lectins in a human epithelial
tumor. Cancer Res. 45:253–257. 1985.PubMed/NCBI
|
|
29
|
Smetana K Jr, Szabo P, Gál P, André S,
Gabius HJ, Kodet O and Dvořánková B: Emerging role of tissue
lectins as microenviron-mental effectors in tumors and wounds.
Histol Histopathol. 30:293–309. 2015.
|
|
30
|
Smetana K Jr, André S, Kaltner H, Kopitz J
and Gabius HJ: Context-dependent multifunctionality of galectin-1:
a challenge for defining the lectin as therapeutic target. Expert
Opin Ther Targets. 17:379–392. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang S, Moussodia RO, Murzeau C, Sun HJ,
Klein ML, Vértesy S, André S, Roy R, Gabius HJ and Percec V:
Dissecting molecular aspects of cell interactions using
glycodendrimer-somes with programmable glycan presentation and
engineered human lectins. Angew Chem Int Ed Engl. 54:4036–4040.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gál P, Vasilenko T, Kostelníková M,
Jakubco J, Kovác I, Sabol F, André S, Kaltner H, Gabius HJ and
Smetana K Jr: Open wound healing in vivo: Monitoring binding and
presence of adhesion/growth-regulatory galectins in rat skin during
the course of complete re-epithelialization. Acta Histochem
Cytochem. 44:191–199. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cooper D, Norling LV and Perretti M: Novel
insights into the inhibitory effects of Galectin-1 on neutrophil
recruitment under flow. J Leukoc Biol. 83:1459–1466. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Emmerson E and Hardman MJ: The role of
estrogen deficiency in skin ageing and wound healing.
Biogerontology. 13:3–20. 2012. View Article : Google Scholar
|
|
35
|
Krahn-Bertil E, Dos Santos M, Damour O,
Andre V and Bolzinger MA: Expression of estrogen-related receptor
beta (ERRβ) in human skin. Eur J Dermatol. 20:719–723.
2010.PubMed/NCBI
|
|
36
|
Campbell L, Emmerson E, Davies F, Gilliver
SC, Krust A, Chambon P, Ashcroft GS and Hardman MJ: Estrogen
promotes cutaneous wound healing via estrogen receptor β
independent of its antiinflammatory activities. J Exp Med.
207:1825–1833. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Boukamp P, Petrussevska RT, Breitkreutz D,
Hornung J, Markham A and Fusenig NE: Normal keratinization in a
spontaneously immortalized aneuploid human keratinocyte cell line.
J Cell Biol. 106:761–771. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guo J, Duckles SP, Weiss JH, Li X and
Krause DN: 17β-Estradiol prevents cell death and mitochondrial
dysfunction by an estrogen receptor-dependent mechanism in
astrocytes after oxygen-glucose deprivation/reperfusion. Free Radic
Biol Med. 52:2151–2160. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kaltner H, Seyrek K, Heck A, Sinowatz F
and Gabius HJ: Galectin-1 and galectin-3 in fetal development of
bovine respiratory and digestive tracts. Comparison of cell
type-specific expression profiles and subcellular localization.
Cell Tissue Res. 307:35–46. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gál P, Kilík R, Mokrý M, Vidinský B,
Vasilenko T, Mozeš S, Bobrov N, Tomori Z, Bober J and Lenhardt L:
Simple method of open skin wound healing model in
corticosteroid-treated and diabetic rats: standardization of
semi-quantitative and quantitative histological assessments. Vet
Med. 53:652–659. 2008.
|
|
41
|
Gál P, Novotný M, Vasilenko T, Depta F,
Šulla I and Tomori Z: Decrease in wound tensile strength following
post-surgical estrogen replacement therapy in ovariectomized rats
during the early phase of healing is mediated via ER-alpha rather
than ER-beta: a preliminary report. J Surg Res. 159:e25–e28. 2010.
View Article : Google Scholar
|
|
42
|
Wegorzewska IN, Walters K, Weiser MJ,
Cruthirds DF, Ewell E, Larco DO, Handa RJ and Wu TJ:
Postovariectomy weight gain in female rats is reversed by estrogen
receptor alpha agonist, propylpyrazoletriol. Am J Obstet Gynecol.
199:67.e1–67.e5. 2008. View Article : Google Scholar
|
|
43
|
Gál P, Toporcer T, Vidinský B, Mokrý M,
Grendel T, Novotný M, Sokolský J, Bobrov N, Toporcerová S, Sabo J
and Mozes S: Postsurgical administration of estradiol benzoate
decreases tensile strength of healing skin wounds in ovariectomized
rats. J Surg Res. 147:117–122. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sanchez-Ruderisch H, Fischer C, Detjen KM,
Welzel M, Wimmel A, Manning JC, André S and Gabius HJ: Tumor
suppressor p16 INK4a: Downregulation of galectin-3, an endogenous
competitor of the pro-anoikis effector galectin-1, in a pancreatic
carcinoma model. FEBS J. 277:3552–3563. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Amano M, Eriksson H, Manning JC, Detjen
KM, André S, Nishimura S, Lehtiö J and Gabius HJ: Tumour suppressor
p16(INK4a) - anoikis-favouring decrease in N/O-glycan/cell surface
sialylation by down-regulation of enzymes in sialic acid
biosynthesis in tandem in a pancreatic carcinoma model. FEBS J.
279:4062–4080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dawson H, André S, Karamitopoulou E,
Zlobec I and Gabius HJ: The growing galectin network in colon
cancer and clinical relevance of cytoplasmic galectin-3 reactivity.
Anticancer Res. 33:3053–3059. 2013.PubMed/NCBI
|
|
47
|
Shon YH, Park SD and Nam KS: Effective
chemopreventive activity of genistein against human breast cancer
cells. J Biochem Mol Biol. 39:448–451. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
DeSantis C, Ma J, Bryan L and Jemal A:
Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014.
View Article : Google Scholar
|
|
49
|
Gabius HJ, Brehler R, Schauer A and Cramer
F: Localization of endogenous lectins in normal human breast,
benign breast lesions and mammary carcinomas. Virchows Arch B Cell
Pathol Incl Mol Pathol. 52:107–115. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Jung EJ, Moon HG, Cho BI, Jeong CY, Joo
YT, Lee YJ, Hong SC, Choi SK, Ha WS, Kim JW, et al: Galectin-1
expression in cancer-associated stromal cells correlates tumor
invasiveness and tumor progression in breast cancer. Int J Cancer.
120:2331–2338. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Dalotto-Moreno T, Croci DO, Cerliani JP,
Martinez-Allo VC, Dergan-Dylon S, Méndez-Huergo SP, Stupirski JC,
Mazal D, Osinaga E, Toscano MA, et al: Targeting galectin-1
overcomes breast cancer-associated immunosuppression and prevents
metastatic disease. Cancer Res. 73:1107–1117. 2013. View Article : Google Scholar
|
|
52
|
Santen RJ, Song RX, Zhang Z, Kumar R, Jeng
MH, Masamura A, Lawrence J Jr, Berstein L and Yue W: Long-term
estradiol deprivation in breast cancer cells up-regulates growth
factor signaling and enhances estrogen sensitivity. Endocr Relat
Cancer. 12(Suppl 1): S61–S73. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Anbalagan M and Rowan BG: Estrogen
receptor alpha phosphorylation and its functional impact in human
breast cancer. Mol Cell Endocrinol. Jan 15–2015.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Novotný M, Vasilenko T, Varinská L,
Smetana K Jr, Szabo P, Sarišský M, Dvořánková B, Mojžiš J, Bobrov
N, Toporcerová S, et al: ER-α agonist induces conversion of
fibroblasts into myofibroblasts, while ER-β agonist increases ECM
production and wound tensile strength of healing skin wounds in
ovariectomised rats. Exp Dermatol. 20:703–708. 2011. View Article : Google Scholar
|
|
55
|
Stevenson S, Nelson LD, Sharpe DT and
Thornton MJ: 17beta-estradiol regulates the secretion of TGF-beta
by cultured human dermal fibroblasts. J Biomater Sci Polym Ed. 19.
pp. 1097–1109. 2008, View Article : Google Scholar
|
|
56
|
Stevenson S, Sharpe DT and Thornton MJ:
Effects of oestrogen agonists on human dermal fibroblasts in an in
vitro wounding assay. Exp Dermatol. 18:988–990. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Merlo S, Frasca G, Canonico PL and Sortino
MA: Differential involvement of estrogen receptor alpha and
estrogen receptor beta in the healing promoting effect of estrogen
in human keratinocytes. J Endocrinol. 200:189–197. 2009. View Article : Google Scholar
|
|
58
|
Gilliver SC, Emmerson E, Campbell L,
Chambon P, Hardman MJ and Ashcroft GS: 17beta-estradiol inhibits
wound healing in male mice via estrogen receptor-alpha. Am J
Pathol. 176:2707–2721. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Grinnell KL and Bickenbach JR: Skin
keratinocytes pre-treated with embryonic stem cell-conditioned
medium or BMP4 can be directed to an alternative cell lineage. Cell
Prolif. 40:685–705. 2007. View Article : Google Scholar : PubMed/NCBI
|
